SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 17, 2008
ICU
MEDICAL, INC.
(Exact name of registrant as specified in its
charter)
|
DELAWARE
|
0-19974
|
33-0022692
|
|
(State or other
jurisdiction of incorporation)
|
(Commission File
Number)
|
(I.R.S. Employer
Identification No.)
|
|
951
Calle Amanecer, San Clemente, California
|
92673
|
|
(Address of principal
executive offices)
|
(Zip
Code)
|
(949)
366-2183
Registrant’s telephone number, including area
code
N/A
(Former name or former address, if changed since
last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
INFORMATION
TO BE INCLUDED IN THE REPORT
Item
1.01 Entry Into a Material
Definitive Agreement
On March 17,
2008 the employment agreement of an officer was amended as
follows:
Mr. Lamb, who
will become Chief Financial Officer effective April 1, 2008: base compensation
increased to $210,000 annually, effective April 1, 2008.
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Report to be signed on its behalf by the undersigned hereunto duly
authorized.
Date: March
19, 2008
ICU MEDICAL,
INC.
/s/ Francis J.
O’Brien
Francis J.
O'Brien
Secretary,
Treasurer and
Chief
Financial Officer